Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Tissue Regeneration in Patients With Chronic Obstructive Pulmonary Disease After an Exercise Intervention.

Activation of Regenerative Pathways by Exercise Training in Patients With Chronic Obstructive Pulmonary Disease

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The main objective of this project is to identify mechanisms for lung regeneration in patients with COPD induced by exercise training. The hypothesis is that adjusted exercise training improves disease outcome in these patients by decrease remodelling processes linked to oxidative stress, inflammatory and/or immunological pathways in the lung. Along the way, the investigator also expect to identify (or validate) biomarkers mirroring systemic processes such as reduced inflammation and ameliorating the epithelial barrier in these patients. These events may additionally act as potential targets for interventions. Objectives (i) Evaluate biomarkers for regenerative processes, matrix turnover, stem cell activity and inflammatory patterns in lung tissue biopsies, blood- and urine samples correlated to vital lung parameters and physical capacity, before and after attending an exercise-training program. (ii) Study the effects of exercise training on the pulmonary ventilation/perfusion ratio and quality of life. (iii) Evaluate the relation between pathophysiology in the lung evaluated by CT scan, and systemic response measured by muscle biopsies and biomarkers in blood/urine. (iv) Investigate in vitro cell behaviour and remodelling/regenerative processes altered in COPD patients upon exercise training (aim 1).

Who May Be Eligible (Plain English)

Who May Qualify: - Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator - Optimal medical treatment according to GOLD and the Swedish National Guidelines - Absence of other significant diseases that could contribute to physical exercise limitation - Non-smoking since at least one year - Free from exacerbations (last 4 weeks) - BMI = 18- 35 Who Should NOT Join This Trial: - Regular participation in adjusted/specially designed exercise sessions - Unstable cardiovascular or pulmonary disease - Smoking - Any other criteria that at the discretion of the investigator prevent the study subject from participating in an exercise-training program Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Forced expiratory volume in one second (FEV1) 85-30 % of predicted post bronchodilator * Optimal medical treatment according to GOLD and the Swedish National Guidelines * Absence of other significant diseases that could contribute to physical exercise limitation * Non-smoking since at least one year * Free from exacerbations (last 4 weeks) * BMI = 18- 35 Exclusion Criteria: * Regular participation in adjusted/specially designed exercise sessions * Unstable cardiovascular or pulmonary disease * Smoking * Any other criteria that at the discretion of the investigator prevent the study subject from participating in an exercise-training program

Treatments Being Tested

OTHER

Exercise regime

Exercise

Locations (2)

Lund University
Lund, Sweden
Uppsala University
Uppsala, Sweden